featured
Lecanemab for Early Alzheimer’s Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Lecanemab in Early Alzheimer’s Disease
N. Engl. J. Med 2022 Nov 29;[EPub Ahead of Print], CH van Dyck, CJ Swanson, P Aisen, RJ Bateman, C Chen, M Gee, M Kanekiyo, D Li, L Reyderman, S Cohen, L Froelich, S Katayama, M Sabbagh, B Vellas, D Watson, S Dhadda, M Irizarry, LD Kramer, T IwatsuboFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.